1.
Donoso P del RQ, Briones RFZ, Castro CPM, Narváez DLB, Velasco SA, Jimenez SNC. Impact of GLP-1 receptor agonists on cardiovascular risk reduction in patients with obesity without type 2 diabetes mellitus: a systematic review. Int J Res Med Sci [Internet]. 2026 Apr. 29 [cited 2026 Apr. 30];14(5):2051-7. Available from: https://www.msjonline.org/index.php/ijrms/article/view/16734